Tyra Biosciences (TYRA) Enterprise Value (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Enterprise Value came in at -$85.0 million in Q1 2026, up 15.65% YoY from -$73.5 million in Q1 2025, and down 9.78% on a QoQ basis from -$77.4 million in Q4 2025.
Tyra Biosciences (TYRA) Enterprise Value (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Enterprise Value data on file, last reported at -$85.0 million in Q1 2026.
- Quarterly Enterprise Value rose 15.65% year-over-year to -$85.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$85.0 million (up 15.65% YoY) and the FY2025 annual result came in at -$77.4 million, up 15.85% from the prior year.
- Enterprise Value retreated to -$85.0 million in Q1 2026, from -$77.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$58.0 million in Q4 2023 to a low of -$292.5 million in Q1 2022.
- A 5-year average of -$164.9 million and a median of -$103.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 107.98% — and 2023, when it surged 76.91%.
- Tracing TYRA's Enterprise Value over 5 years: stood at -$251.2 million in 2022, then surged by 76.91% to -$58.0 million in 2023, then tumbled by 58.55% to -$92.0 million in 2024, then increased by 15.85% to -$77.4 million in 2025, then declined by 9.78% to -$85.0 million in 2026.
- The last three Enterprise Value figures came in at -$85.0 million (Q1 2026), -$77.4 million (Q4 2025), and -$62.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | -73.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.84 Mn |
| Mar 31, 2026 | -84.96 Mn |
| Dec 31, 2025 | -77.39 Mn |
| Sep 30, 2025 | -61.95 Mn |
| Jun 30, 2025 | -98.49 Mn |
| Mar 31, 2025 | -100.72 Mn |
| Dec 31, 2024 | -91.97 Mn |
| Sep 30, 2024 | -103.89 Mn |
| Jun 30, 2024 | -99.49 Mn |
| Mar 31, 2024 | -254.37 Mn |
| Dec 31, 2023 | -58.01 Mn |
| Sep 30, 2023 | -215.65 Mn |
| Jun 30, 2023 | -232.41 Mn |
| Mar 31, 2023 | -241.70 Mn |
| Dec 31, 2022 | -251.21 Mn |
| Sep 30, 2022 | -263.21 Mn |
| Jun 30, 2022 | -275.11 Mn |
| Mar 31, 2022 | -292.50 Mn |
| Dec 31, 2021 | -302.18 Mn |
| Sep 30, 2021 | -312.82 Mn |